Osimertinib-impurities | Pharmaffiliates

osimertinib

Osimertinib is used to treat locally advanced or metastatic non-small-cell lung cancer. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.Reference standards of Osimertinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => 2,4-Difluoronitrobenzene (BSC)
    [catalogue_number] => PA BSC 05115877
    [category_ids] => ,169,
    [chemical_name] => 
    [weight] => 159.09
    [form] => C6H3F2NO2
    [cas] => 446-35-5
    [pslug] => 446-35-5-2-4-difluoronitrobenzene-bsc-pabsc05115877
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA BSC 05115877

2,4-Difluoronitrobenzene (BSC)


  • Catalogue No.:PA BSC 05115877

  • CAS :

    446-35-5

  • Molecular Formula : C6H3F2NO2

  • Molecular Weight : 159.09